TY - JOUR
T1 - Physician-Industry Collaboration
T2 - Organizational Considerations for the Future of Innovation and Growth in Dermatology
AU - WDS Industry Visioning Work Group
AU - Roberts, Wendy E.
AU - Sadick, Neil S.
AU - Bergfeld, Wilma F.
AU - Paller, Amy S.
AU - Callender, Valerie D.
AU - Drake, Lynn A.
AU - Gilbert, Erin
AU - Draelos, Zoe
AU - Foster, Diane
AU - Lupo, Mary
AU - Butterwick, Kimberly
AU - Hebert, Adelaide
AU - McDonald, Michel
AU - Gohara, Mona A.
AU - Hodge, Julie
AU - Rendon, Marta
AU - Waldorf, Heidi
AU - Lucas, Jennifer
AU - Stewart, Kristen
AU - Kourosh, Arianne Shadi
AU - Hectorne, Kathleen J.
AU - Hickman, Janet G.
AU - Spera, Alison
AU - Salo, Lynn
AU - Clark, Steve
AU - Antunes, Humberto
AU - Madden, Mary
AU - Steele, Tyler
AU - Grant, Robert
AU - Smith, Ann
AU - Johnson, Brian
AU - Colon, Gene
AU - Barrineau, Michelle
AU - Humphries, William
AU - Hartman, Jim
AU - Cropper, Shelly
AU - Reynolds, Brittany
AU - O'Connell, Jim
AU - Hunt, Niquette
AU - Pilcher, Brian
AU - Ryan, Lori
AU - Kennedy, Sheila
AU - Williams, Glenn
AU - Hahn, Charles
AU - Weldon, Ryan
N1 - Publisher Copyright:
© 2016 The Authors.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - The U.S. medical environment continues to evolve with issues from Privacy to EMR, Insurance regulations, Physician Access and Healthcare Reform, and MACRA (Medicare Access and CHIP Reauthorization Act) on the discussion table. Not since the advent of Medicare and Medicaid in the mid 1960's, have we seen such widespread changes in the medical healthcare environment (Centers for Medicare and Medicaid Services). Physicians, industry, patients and consumers are affected by the changes. These four groups have historically worked as separate entities, but are now key stakeholders in the future of dermatology. As stakeholders collaborating in building a future together, the dermatologists/physicians will help to ensure and preserve the quality of patient care and best patient outcomes. In the Executive Forum, leaders from the Women's Dermatologic Society and Industry, explored five important areas: 1) A five-year outlook of Dermatology and Medicine; 2) Access of Industry to Dermatologists and Trainees; 3) The New Practice Environment; 4) Doing Things Differently; and 5) Unmet Specialty Needs. The collaborative group explored solutions for our specialty and the patients we serve.
AB - The U.S. medical environment continues to evolve with issues from Privacy to EMR, Insurance regulations, Physician Access and Healthcare Reform, and MACRA (Medicare Access and CHIP Reauthorization Act) on the discussion table. Not since the advent of Medicare and Medicaid in the mid 1960's, have we seen such widespread changes in the medical healthcare environment (Centers for Medicare and Medicaid Services). Physicians, industry, patients and consumers are affected by the changes. These four groups have historically worked as separate entities, but are now key stakeholders in the future of dermatology. As stakeholders collaborating in building a future together, the dermatologists/physicians will help to ensure and preserve the quality of patient care and best patient outcomes. In the Executive Forum, leaders from the Women's Dermatologic Society and Industry, explored five important areas: 1) A five-year outlook of Dermatology and Medicine; 2) Access of Industry to Dermatologists and Trainees; 3) The New Practice Environment; 4) Doing Things Differently; and 5) Unmet Specialty Needs. The collaborative group explored solutions for our specialty and the patients we serve.
UR - http://www.scopus.com/inward/record.url?scp=84975110953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84975110953&partnerID=8YFLogxK
U2 - 10.1016/j.ijwd.2016.06.001
DO - 10.1016/j.ijwd.2016.06.001
M3 - Editorial
C2 - 28492008
AN - SCOPUS:84975110953
VL - 2
SP - 60
EP - 61
JO - International Journal of Women's Dermatology
JF - International Journal of Women's Dermatology
SN - 2352-6475
IS - 2
ER -